Adaxion Therapeutics is transforming the future of biotherapeutics by tackling one of the biggest challenges in drug development: immunogenicity
Adaxion Therapeutics is transforming the future of biotherapeutics by tackling one of the biggest challenges in drug development: immunogenicity. The company is developing innovative treatments for immune-mediated and inflammatory diseases using its proprietary ADAx platform, designed to deimmunize protein therapeutics and enhance therapeutic performance.